Daewoong Pharmaceuticals

Seoul,  Gangnam-gu 
Korea (South)
http://www.cgbio.com
  • Booth: 2259

Cell & Growth Factor Biotechnology Company

About Us

Daewoong Group is a global healthcare group established in 1945 under the vision to 'manufacture high-quality pharmaceuticals and medical devices to enhance people’s health and create a healthy society'.

Area of Business

Orthopedic Industry / Wound care Industry / Aesthetic

Number of Employees worldwide

more than 3,500

Year of Foundation

1945

Sales Volume

1.4 B USD

Core Product

1. Mediclore: Thermo-sensitive Anti-Adhesion barrier Sol-Gel type
2. Novomax: Osteo-active Cervical & Lumbar Spacer
3. Novosis: E.coli derived rhBMP-2
4. DBM: Fiber type DBM
5. Spinal Implant: Pedicle screw, ACP, Cages
..

Brands: 1. Mediclore: Thermo-sensitive Anti-Adhesion barrier Sol-Gel type 2. Novomax: Osteo-active Cervical & Lumbar Spacer 3. Novosis: E.coli derived rhBMP-2 4. DBM: Fiber type DBM